Natalia Wegner
Natalia specialises in complex biotechnological subject matter, in particular cell and gene therapies, nucleic acid technologies, antibody-based drugs and engineered therapeutic proteins. She handles mainly European prosecution and opposition cases that require a coordinated strategic approach and often involve multiple parties and associated ongoing or looming disputes. Natalia has particular experience obtaining and defending key patents in relation to commercially valuable products and technologies, as well as advising on and attacking competitors’ IP. A large part of Natalia’s work also involves advising on SPCs, and she has been closely involved in high profile SPC litigation nationally and at the CJEU. Natalia was named as a Notable Practitioner in IP by Managing IP in 2024 and a Rising Star in 2020, 2021, 2022 and 2023. · Carpmaels & Ransford LLP
About
Natalia is a life sciences IP specialist at Carpmaels & Ransford LLP who focuses on complex biotechnological subject matter, including cell and gene therapies, nucleic acid technologies, antibody-based drugs and engineered therapeutic proteins, and handles European patent prosecution and opposition work requiring coordinated strategic approaches. She also advises on and has been closely involved in high‑profile Supplementary Protection Certificate (SPC) litigation nationally and at the CJEU; she was named a Notable Practitioner in IP by Managing IP in 2024 and a Rising Star in 2020–2023.
Practice areas
Office
Expertise
Education
- BSc Biochemistry, Technical University Munich
- MRes Biochemical Research (Distinction), Imperial College London
- PhD Immunology, Imperial College London
Admissions
- Chartered Patent Attorney (qualified 2015)
- European Patent Attorney (qualified 2015)
- Intellectual Property Litigation Certificate (2016)
- UPC Representative